Irisin, by activating NRF2, inhibiting NF-κB, and enhancing MAPK1/3 signaling, addresses key pathological features of AD, including oxidative stress, inflammation, and neuronal dysfunction. The gene discussed is FNDC5; the disease is Alzheimer disease.